September 18, 2021

MoviesOnline

Complete Canadian News World

Corona virus vaccine.  Spikevax from Moderna.  It will be open to young people between the ages of 12 and 18

Corona virus vaccine. Spikevax from Moderna. It will be open to young people between the ages of 12 and 18

Moderna’s Spikevax has been formulated for children and teens ages 12 to 18 since Friday, according to the Department of Health. The ministry also published a schedule for administering a vaccine for this age group.

At the end of July, the European Medicines Agency (EMA) approved the Moderna COVID-19 vaccine for children and adolescents aged 12-18 years. Previously, this was only possible with Pfizer. The Ministry of Health reports that in Poland, this age group can be vaccinated with Moderna from Friday.

Watch TVN24 live on TVN24 GO >>>

Vaccination schedules for people up to 18 years of age

The ministry also published a communication about the vaccination schedules used in people up to 18 years of age.

Accordingly, in the case of the Comirnata vaccine (Pfizer/BioNTech), the recommended interval between two doses should be 21 days. On the other hand, for Spikevax (Moderny) vaccine, a period of 28 days is recommended.

Communication regarding vaccination schedules used against COVID-19 with Comirnata and Spikevax in children and adolescents up to 18 years of age

The report emphasized that the recommendations are in line with the characteristics of medicinal products.

Read more about Konkret24: Vaccinations of Poles and age

In order to obtain maximum protection from COVID-19, including disease caused by the delta variant of SARS-CoV-2, it is important to administer two doses of the vaccine without unreasonably prolonging the intervals between doses.

Adolescent vaccinations

According to EMA information, Moderny’s effects were analyzed in a study of 3,732 children between the ages of 12 and 17. It showed that the vaccine produced an immune response comparable to that of the 18-25-year-old. Among the 2,163 children who received the real vaccine, no symptoms of COVID-19 developed. In a group of 1,073 children who received a placebo, four people developed symptoms. Based on these findings, the EMA concluded that Moderny’s effectiveness in children 12 to 17 years of age is similar to that of adults.

The most common side effects in children aged 12 to 17 are similar to those in people aged 18 and over. These include pain and swelling at the injection site, fatigue, headache, muscle and joint pain, swollen lymph nodes, chills, nausea, vomiting and fever, the agency said. These symptoms are usually mild to moderate and disappear within a few days of vaccination.

Number of people vaccinated in Poland

By Friday, 3,528,1208 doses of COVID-19 vaccines had been administered. The first dose was 18,759,946 vaccinations. 18,064,134 people were fully vaccinated – with either a single dose of Johnson & Johnson or a second dose of AstraZeneca, Moderna or Pfizer/BioNTech vaccines.

Main image source: stock struggle

See also  The third dose is for people over 65 years of age and especially vulnerable